This medical tool provides clinicians with quick access to risk prediction and volume doubling time calculators for pulmonary nodules. It incorporates recommendations from the British Thoracic Society to aid in diagnosis and patient management, summarizing key guidelines.
2.0.2
October 10, 2017
This app has been updated by Apple to display the Apple Watch app icon. Minor bug fixes.
MorePulmonary Nodule Risk includes the Brock and Herder risk prediction calculators, along with a volume doubling time (VDT) calculator. These tools are recommended by the British Thoracic Society (BTS) for assessing and managing pulmonary nodules.
Pulmonary Nodule Risk was developed by Cancer Research UK in collaboration with the British Thoracic Society (BTS). This partnership aims to provide clinicians with easy access to essential diagnostic and management tools.
No, Pulmonary Nodule Risk is designed as a tool for clinicians. Patients concerned about their lung health or scan results should consult their doctor or GP. Cancer Research UK also offers patient information resources.
The app incorporates recommendations from the British Thoracic Society (BTS) guidelines for the investigation and management of pulmonary nodules. It includes four management algorithms summarized from the full BTS Guidelines published in 2015.
Pulmonary Nodule Risk is available on iPhone, iPad, and iPod. It is designed to be accessible on Apple's mobile operating systems.
The latest version of Pulmonary Nodule Risk is 2.0.2, last updated on October 10, 2017. The app was initially released on December 2, 2016.
Pulmonary Nodule Risk has an age rating of 17+. This indicates that the content is intended for mature audiences, likely due to the medical nature of the information presented.
No, Pulmonary Nodule Risk does not contain advertisements. As a free medical tool developed by Cancer Research UK, it focuses on providing clinical information without commercial interruptions.
